Wellington Management Group LLP Theravance Biopharma, Inc. Transaction History

Wellington Management Group LLP

  • $557 Billion
  • Q3 2024

A detailed history of Wellington Management Group LLP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 191,329 shares of TBPH stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
191,329
Previous 350,587 45.43%
Holding current value
$1.91 Million
Previous $2.97 Million 48.12%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$7.66 - $10.25 $1.22 Million - $1.63 Million
-159,258 Reduced 45.43%
191,329 $1.54 Million
Q2 2024

Aug 13, 2024
BUY
$8.29 - $9.92 $162,691 - $194,680
19,625 Added 5.93%
350,587 $2.97 Million
Q1 2024

May 15, 2024
BUY
$8.22 - $11.59 $2.72 Million - $3.84 Million
330,962 New
330,962 $2.97 Million
Q4 2023

Feb 12, 2024
BUY
$8.58 - $11.4 $2.46 Million - $3.27 Million
287,102 New
287,102 $3.23 Million
Q3 2023

Nov 14, 2023
SELL
$8.38 - $10.44 $94,878 - $118,201
-11,322 Reduced 6.21%
170,938 $1.48 Million
Q2 2023

Aug 14, 2023
BUY
$10.16 - $11.92 $426,709 - $500,628
41,999 Added 29.94%
182,260 $1.89 Million
Q1 2023

May 12, 2023
SELL
$9.87 - $11.44 $31,297 - $36,276
-3,171 Reduced 2.21%
140,261 $1.52 Million
Q4 2022

Feb 13, 2023
SELL
$9.65 - $11.34 $77,952 - $91,604
-8,078 Reduced 5.33%
143,432 $1.61 Million
Q3 2022

Nov 14, 2022
BUY
$8.39 - $10.22 $33,912 - $41,309
4,042 Added 2.74%
151,510 $1.54 Million
Q2 2022

Aug 15, 2022
SELL
$8.41 - $10.34 $7,728 - $9,502
-919 Reduced 0.62%
147,468 $1.34 Million
Q1 2022

May 16, 2022
SELL
$8.33 - $12.96 $413,726 - $643,684
-49,667 Reduced 25.08%
148,387 $1.42 Million
Q4 2021

Feb 11, 2022
SELL
$7.42 - $11.05 $387,064 - $576,423
-52,165 Reduced 20.85%
198,054 $2.19 Million
Q3 2021

Nov 15, 2021
SELL
$6.77 - $14.41 $57.4 Million - $122 Million
-8,477,105 Reduced 97.13%
250,219 $1.85 Million
Q2 2021

Aug 16, 2021
BUY
$14.52 - $22.46 $18.3 Million - $28.4 Million
1,263,122 Added 16.92%
8,727,324 $127 Million
Q1 2021

May 17, 2021
BUY
$16.57 - $21.08 $33.1 Million - $42.1 Million
1,996,902 Added 36.52%
7,464,202 $152 Million
Q4 2020

Feb 12, 2021
BUY
$14.89 - $20.16 $11 Million - $14.9 Million
739,708 Added 15.65%
5,467,300 $97.2 Million
Q3 2020

Nov 16, 2020
BUY
$14.79 - $22.49 $3.62 Million - $5.51 Million
244,815 Added 5.46%
4,727,592 $69.9 Million
Q2 2020

Aug 14, 2020
BUY
$20.64 - $30.69 $6.51 Million - $9.68 Million
315,254 Added 7.56%
4,482,777 $94.1 Million
Q1 2020

May 14, 2020
BUY
$17.84 - $31.21 $17.7 Million - $30.9 Million
989,986 Added 31.16%
4,167,523 $96.3 Million
Q4 2019

Feb 11, 2020
BUY
$16.12 - $25.89 $51.2 Million - $82.3 Million
3,177,537 New
3,177,537 $82.3 Million

Others Institutions Holding TBPH

# of Institutions
122
Shares Held
47.3M
Call Options Held
200
Put Options Held
12.8K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $666M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email